Loading clinical trials...
Loading clinical trials...
The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also inten...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Atrium Medical Corporation
NCT06112171 · Peripheral Arterial Disease
NCT03663777 · Peripheral Arterial Disease
NCT07497360 · Peripheral Arterial Disease
NCT04584632 · Peripheral Arterial Disease, Vascular Diseases, and more
NCT07157475 · Peripheral Arterial Disease(PAD)
Massachusetts General Hospital
Boston, Massachusetts
CHU de Brest
Brest, Brittany Region
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions